BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25203537)

  • 1. HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology.
    Sako N; Dessirier V; Bagot M; Bensussan A; Schmitt C
    Am J Pathol; 2014 Nov; 184(11):2899-907. PubMed ID: 25203537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.
    Huang Y; de Reyniès A; de Leval L; Ghazi B; Martin-Garcia N; Travert M; Bosq J; Brière J; Petit B; Thomas E; Coppo P; Marafioti T; Emile JF; Delfau-Larue MH; Schmitt C; Gaulard P
    Blood; 2010 Feb; 115(6):1226-37. PubMed ID: 19965620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular underpinning of extranodal NK/T-cell lymphoma.
    Huang Y; de Leval L; Gaulard P
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):57-74. PubMed ID: 23768641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.
    Küçük C; Hu X; Iqbal J; Gaulard P; Klinkebiel D; Cornish A; Dave BJ; Chan WC
    Am J Pathol; 2013 Jan; 182(1):49-55. PubMed ID: 23142381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of evidence that HACE1 is not a tumor suppressor gene in NKTCL: to the editor-in-chief.
    Küçük C; Hu X; McKeithan T; Chan WC
    Am J Pathol; 2015 Apr; 185(4):1167-8. PubMed ID: 25794710
    [No Abstract]   [Full Text] [Related]  

  • 6. Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma.
    Chen YW; Guo T; Shen L; Wong KY; Tao Q; Choi WW; Au-Yeung RK; Chan YP; Wong ML; Tang JC; Liu WP; Li GD; Shimizu N; Loong F; Tse E; Kwong YL; Srivastava G
    Blood; 2015 Mar; 125(10):1589-600. PubMed ID: 25612622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of evidence that HACE1 is not a tumor suppressor gene in NKTCL: to the editor-in-chief. Authors' reply.
    Schmitt C; Sako N; Bagot M; Bensussan A
    Am J Pathol; 2015 Apr; 185(4):1168. PubMed ID: 25794711
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study in multiple populations.
    Lin GW; Xu C; Chen K; Huang HQ; Chen J; Song B; Chan JKC; Li W; Liu W; Shih LY; Chuang WY; Kim WS; Tan W; Peng RJ; Laurensia Y; Cheah DMZ; Huang D; Cheng CL; Su YJ; Tan SY; Ng SB; Tang TPL; Han K; Wang VY; Jia WH; Pei Z; Li YJ; Gao S; Shi Y; Hu Z; Zhang F; Zhang B; Zeng YX; Shen H; He L; Ong CK; Lim ST; Chanock S; Kwong YL; Lin D; Rothman N; Khor CC; Lan Q; Bei JX;
    Lancet Oncol; 2020 Feb; 21(2):306-316. PubMed ID: 31879220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.
    Schmitt C; Sako N; Bagot M; Huang Y; Gaulard P; Bensussan A
    J Biomed Biotechnol; 2011; 2011():790871. PubMed ID: 21541194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-13 and IL-13Rα1 are overexpressed in extranodal natural killer/T cell lymphoma and mediate tumor cell proliferation.
    Zhang Y; Li C; Zhang M; Li Z
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2715-2720. PubMed ID: 30107911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway.
    Sui X; Zhang C; Zhou J; Cao S; Xu C; Tang F; Zhi X; Chen B; Wang S; Yin L
    J Exp Clin Cancer Res; 2017 Sep; 36(1):133. PubMed ID: 28950914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study.
    Li Z; Xia Y; Feng LN; Chen JR; Li HM; Cui J; Cai QQ; Sim KS; Nairismägi ML; Laurensia Y; Meah WY; Liu WS; Guo YM; Chen LZ; Feng QS; Pang CP; Chen LJ; Chew SH; Ebstein RP; Foo JN; Liu J; Ha J; Khoo LP; Chin ST; Zeng YX; Aung T; Chowbay B; Diong CP; Zhang F; Liu YH; Tang T; Tao M; Quek R; Mohamad F; Tan SY; Teh BT; Ng SB; Chng WJ; Ong CK; Okada Y; Raychaudhuri S; Lim ST; Tan W; Peng RJ; Khor CC; Bei JX
    Lancet Oncol; 2016 Sep; 17(9):1240-7. PubMed ID: 27470079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
    Ma H; Shen L; Yang H; Gong H; Du X; Li J
    IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Genetic Deletion of 6q21 and PRDM1 and Clinical Implications in Extranodal NK/T Cell Lymphoma, Nasal Type.
    Liang L; Zhang Z; Wang Y; Nong L; Zheng Y; Qu L; Zhang B; Li T
    Biomed Res Int; 2015; 2015():435423. PubMed ID: 26221594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived growth factor receptor alpha (PDGFRα) is overexpressed in NK/T-cell lymphoma and mediates cell survival.
    Lu L; Fu X; Li Z; Qiu Y; Li W; Zhou Z; Xue W; Wang Y; Jin M; Zhang M
    Biochem Biophys Res Commun; 2018 Oct; 504(2):525-531. PubMed ID: 30201265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations.
    Bouzelfen A; Alcantara M; Kora H; Picquenot JM; Bertrand P; Cornic M; Mareschal S; Bohers E; Maingonnat C; Ruminy P; Adriouch S; Boyer O; Dubois S; Bastard C; Tilly H; Latouche JB; Jardin F
    Leuk Res; 2016 Jun; 45():90-100. PubMed ID: 27107267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of PRDM1/Blimp-1 promoter in extranodal NK/T-cell lymphoma, nasal type: an evidence of predominant role in its downregulation.
    Zhang Z; Liang L; Li D; Nong L; Liu J; Qu L; Zheng Y; Zhang B; Li T
    Hematol Oncol; 2017 Dec; 35(4):645-654. PubMed ID: 27704586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between higher expression of YB-1 and poor prognosis in early-stage extranodal nasal-type natural killer/T-cell lymphoma.
    Zhao Z; Liao Y; Li J; Wu J; Zhang Y; Feng G; Tan B; Reng S; Zhang Z; Feng X; Wang J; Du X
    Biomark Med; 2014; 8(4):581-8. PubMed ID: 24796623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p63 and p53 expression in extranodal NK/T cell lymphoma, nasal type.
    Ye Z; Cao Q; Niu G; Liang Y; Liu Y; Jiang L; Yu X; Han A
    J Clin Pathol; 2013 Aug; 66(8):676-80. PubMed ID: 23626008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney.
    Anglesio MS; Evdokimova V; Melnyk N; Zhang L; Fernandez CV; Grundy PE; Leach S; Marra MA; Brooks-Wilson AR; Penninger J; Sorensen PH
    Hum Mol Genet; 2004 Sep; 13(18):2061-74. PubMed ID: 15254018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.